Docon Technologies Pvt Ltd, a 100 percent subsidiary of PharmEasy#39;s parent firm API, will be the acquirer and shall make an open offer for an additional 26 percent stake.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
The company#39;s vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - Natio...
No comments:
Post a Comment